Better Prognosis by early Salvage Radiotherapy (PSA <0.2 ng/ml) in PSA-Progression after Prostate Cancer Surgery

被引：0
|
作者：
Thamm, R. [1 ]
Bartkowiak, D. [1 ]
Bottke, D. [2 ]
Siegmann, A. [3 ]
Boehmer, D. [3 ]
Budach, V [3 ]
Wiegel, T. [1 ]
机构：
[1] Univ Klinikum Ulm, Klin Strahlentherapie & Radioonkol, Ulm, Germany
[2] Klinikum Esslingen, Klin Strahlentherapie & Radioonkol, Esslingen, Germany
[3] Charite Univ Med Berlin, Klin Radioonkol & Strahlentherapie, CBF, Berlin, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2016年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V16-1
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [1] The PSA nadir coal for radiotherapy of prostate cancer is ≤0.2 ng/ml
    Critz, FA
    Levinson, AK
    Williams, WH
    Holladay, DA
    Holladay, CT
    Griffin, VD
    JOURNAL OF UROLOGY, 1998, 159 (05): : 218 - 218
  • [2] Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
    Bottke, Dirk
    Bartkowiak, Detlef
    Siegmann, Alessandra
    Thamm, Reinhard
    Bohmer, Dirk
    Budach, Volker
    Wiegel, Thomas
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (02) : 344 - 349
  • [3] Salvage Radiotherapy for PSA <0.2 vs. 0.2 to <0.5 ng / ml and prognostic Significance of the post-SRT PSA Nadir in postoperatively relapsed Prostate Cancer
    Thamm, R.
    Bartkowiak, D.
    Bottke, D.
    Siegmann, A.
    Boehmer, D.
    Wiegel, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S19 - S19
  • [4] PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
    Nantia Solomonidou
    Daphnie Germanou
    Iosif Strouthos
    Efstratios Karagiannis
    Andrea Farolfi
    Stefan A. Koerber
    Juergen Debus
    Jan C. Peeken
    Marco E. Vogel
    Alexis Vrachimis
    Simon K. B. Spohn
    Mohamed Shelan
    Daniel Aebersold
    Anca-Ligia Grosu
    Francesco Ceci
    Stephanie G. C. Kroeze
    Matthias Guckenberger
    Stefano Fanti
    Claus Belka
    George Hruby
    S. Scharl
    Thomas Wiegel
    Peter Bartenstein
    Christoph Henkenberens
    Louise Emmett
    Nina Sophie Schmidt-Hegemann
    Konstantinos Ferentinos
    Constantinos Zamboglou
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2529 - 2536
  • [5] PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
    Solomonidou, Nantia
    Germanou, Daphnie
    Strouthos, Iosif
    Karagiannis, Efstratios
    Farolfi, Andrea
    Koerber, Stefan A. A.
    Debus, Juergen
    Peeken, Jan C. C.
    Vogel, Marco E. E.
    Vrachimis, Alexis
    Spohn, Simon K. B.
    Shelan, Mohamed
    Aebersold, Daniel
    Grosu, Anca-Ligia
    Ceci, Francesco
    Kroeze, Stephanie G. C.
    Guckenberger, Matthias
    Fanti, Stefano
    Belka, Claus
    Hruby, George
    Scharl, S.
    Wiegel, Thomas
    Bartenstein, Peter
    Henkenberens, Christoph
    Emmett, Louise
    Schmidt-Hegemann, Nina Sophie
    Ferentinos, Konstantinos
    Zamboglou, Constantinos
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2529 - 2536
  • [6] PSA velocity threshold for predicting prostate cancer in young men with PSA &lt; 4 ng/ml
    Loeb, S
    Roehl, KA
    Graif, T
    Viprakasit, D
    Catalona, WJ
    Nadler, RB
    JOURNAL OF UROLOGY, 2006, 175 (04): : 153 - 153
  • [7] Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
    Dirk Bottke
    Detlef Bartkowiak
    Alessandra Siegmann
    Reinhard Thamm
    Dirk Böhmer
    Volker Budach
    Thomas Wiegel
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 344 - 349
  • [8] Pathologic stage and surgical outcomes of prostate cancer with PSA &lt; 4 ng/ml
    Gashti, SN
    Han, M
    Hawkins, SA
    Roehl, KA
    Loeb, S
    Catalona, WJ
    JOURNAL OF UROLOGY, 2006, 175 (04): : 170 - 171
  • [9] The Impact of Undetectable PSA After Salvage Radiotherapy for Prostate Cancer
    Rodrigues, I.
    Ferreira, C.
    Goncalves, J.
    Carvalho, L.
    Oliveira, J.
    Castro, C.
    Oliveira, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S608 - S608
  • [10] Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA &lt;20 ng/ml
    Chang, Tsung-Hsin
    Lin, Wun-Rong
    Tsai, Wei-Kung
    Chiang, Pai-Kai
    Chen, Marcelo
    Tseng, Jen-Shu
    Chiu, Allen W.
    BMC UROLOGY, 2020, 20 (01)
12345